Hostname: page-component-89b8bd64d-mmrw7 Total loading time: 0 Render date: 2026-05-09T11:18:47.776Z Has data issue: false hasContentIssue false

Tramadol, captagon and khat use in the Eastern Mediterranean Region: opening Pandora's box

Published online by Cambridge University Press:  19 November 2021

Hossein Mohaddes Ardabili
Affiliation:
Psychiatry Resident, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; and International Society of Addiction Medicine New Professionals Exploration, Training & Education Committee (ISAM NExT), Calgary, Canada
Abolfazl Akbari
Affiliation:
Medical Student, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Parnian Rafei
Affiliation:
MSc. Clinical Psychology, Department of Psychology, Faculty of Psychology and Education, University of Tehran, Iran; and International Society of Addiction Medicine New Professionals Exploration, Training & Education Committee (ISAM NExT), Calgary, Canada
JL Butner
Affiliation:
Addiction Medicine Specialist, International Society of Addiction Medicine New Professionals Exploration, Training & Education Committee (ISAM NExT), Calgary, Canada
Riaz Khan
Affiliation:
Professor, Psychiatry Specialist, Department of Psychiatry, Frontier Medical College, Affiliated to Bahria University, Abbottabad, Pakistan
Yasser Khazaal
Affiliation:
Full Professor of Addiction Psychiatry, Addiction Medicine, Department of Psychiatry, Lausanne University Hospital and Lausanne University, Switzerland
Abdulmalik Zuhair Arab
Affiliation:
PG Researcher, Division of Systems Medicine, School of Medicine, University of Dundee, UK
Mohammed Rafiq Qazizada
Affiliation:
Dr., Communicable Diseases Control Directorate, National AIDs Control Program, Communicable Diseases Control Directorate, Ministry of Public Health, Kabul, Afghanistan
Basma Al-Ansari
Affiliation:
PhD Addiction Medicine, Addiction Medicine, Sydney Medical School, University of Sydney, NSW, Australia
Alexander Mario Baldacchino
Affiliation:
Medicine, Psychiatry and Addictions Professor, Division of Population and Behavioural Science, School of Medicine, University of St Andrews, UK. Email amb30@st-andrews.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

As defined by the World Health Organization, the Eastern Mediterranean Region (EMR), given its special geopolitical situation and internal/external conflicts, faces an increase in illegal activities such as drug production and trafficking, highlighting the need for a comprehensive understanding of the substance use situation. On the basis of a review of published papers between 2015 and 2021 we briefly review substance use in the EMR with special focus on the emerging drugs pertinent to this region, namely tramadol, captagon and khat.

Information

Type
Thematic Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists
Figure 0

Fig. 1 Impact of drugs in the Eastern Mediterranean region (EMR).4–6 DALY, disability-adjusted life-year.

Figure 1

Fig. 2 Age-standardised disability-adjusted life-years (DALYs) per 100 000 people (2016) and total DALYs (’000) (2015) in the Eastern Mediterranean region compared with the global estimate.8,9 Some data were not available.

Supplementary material: File

Mohaddes Ardabili et al. supplementary material

Mohaddes Ardabili et al. supplementary material

Download Mohaddes Ardabili et al. supplementary material(File)
File 16.3 KB
Submit a response

eLetters

No eLetters have been published for this article.